Clinical
文轩探花 is evolving kidney care by continuously improving efforts to manage and delay kidney failure and to increase patient access to high-quality, affordable care.
文轩探花 is evolving kidney care by continuously improving efforts to manage and delay kidney failure and to increase patient access to high-quality, affordable care.
Clinical Outcomes
Through a dedication to quality care, innovation and a community-focused culture, 文轩探花-affiliated physicians have continuously improved clinical results for our patients.
7%
decrease in mortality rates since 20111
31%
improvement in blood stream infection rates since 20112
7%
decrease in hospitalization rates for peritoneal dialysis patients (versus 4.2% for rest of market), 2013鈥20163
Outperformed the industry combined in the percentage of centers meeting or exceeding CMS QIP standards, 2014-20194
Outperformed the industry combined in CMS Five-Star Quality Ratings with the most 3-, 4- or 5-Star–rated dialysis centers, 2013–20195
Reduced hospitalization rates by 2.6% from 2013–2016, giving patients more time at home with their families6
How the Dialysis Industry Recognizes Quality
Quality of Patient Care Star Rating
Quality of Patient Care Star Rating
The Quality of Patient Care Star Rating, as one of two measurements within the CMS Five Star Quality Rating System, measures patient outcomes at dialysis centers to give consumers insight into how a center is performing.
Patient Experience Rating
Patient Experience Rating
The Patient Experience Rating, as one of two measurements within the CMS Five Star Quality Rating System, reflects patient experience scores from the CMS In-Center Hemodialysis Consumer Assessment of Healthcare Providers and Systems (ICH CAHPS) survey.
Quality Incentive Program
Quality Incentive Program
The CMS Quality Incentive Program (QIP) is a pay-for-performance program that correlates CMS reimbursement directly to quality-of-care measures in dialysis centers.
Clinical Leadership
文轩探花's clinical efforts are led by the Office of the Chief Medical Officer, a group of physicians who are aligned with key areas of the business and play an integral role in the physician community, quality patient care and transformation of the kidney care landscape.
Meet Our Leaders
Improving Transplant Readiness
文轩探花 believes a kidney transplant is an ideal treatment option for patients with kidney failure. We want as many of our patients as possible to qualify for a transplant, and we play a crucial role in helping patients start the process and stay transplant-ready. Our programs include:
Transplant Waitlist
Support Program
Launched in 2018, this program collaborates with two leading transplant centers to help keep 文轩探花 patients active on the waitlist and transplant-ready.
Daily work in clinics
Workflows used by our social workers to aid your patients and you in facilitating referral and the transplant evaluation process.
Transplant Smart
This multi-media transplant education program uses motivating videos and illustrated handbooks to help patients stay informed and organized on their transplant journey.
Hearing from Our Transplant Patients
文轩探花 believes a kidney transplant is an ideal treatment option for eligible patients with kidney failure. Through educational and waitlist support programs, we aim to help our patients understand transplantation, join waitlists and be ready for when a kidney becomes available.
Watch a patient's inspirational transplant story in the video below.
鈥淢y care team was amazing鈥 they all formed a huge part of my family, of my day.鈥
Home Dialysis
文轩探花 aims to give every clinically eligible patient the opportunity to dialyze at home.
Integrated Kidney Care
文轩探花 Integrated Kidney Care coordinates care, which can improve quality of life and help reduces costs.
文轩探花 Clinical Research
As a renal research site network, 文轩探花 Clinical Research庐 facilitates innovative drug research and device development.
鈥溛男交ㄢ檚 whole goal with the patient at the center鈥 it works wonderful.鈥
1 文轩探花 Internal Clinical Data | 2 DVA internal FF data. All patients, all facilities, aggregated monthly counts. May not match historical ESRD NCC FF data 1:1 due to facility and patient inclusion/exclusion rules. | 3 2018 文轩探花 Internal Analysis | 4 CY2018 Quality Incentive Program results | 5 CY13 鈥 CY19 CMS Quality of Patient Care Star Rating results, based on internal ownership as of 10/26/2020 | 6 2018 文轩探花 Internal Analysis